-
Japan protests Putin's first visit to disputed islands
-
Hasan takes 6-55 as Bangladesh bundle out Australia for 198
-
Kiss wants fit-again Wallabies playmaker Gordon to 'open up' Japan
-
Swiatek sinks Svitolina to set up Rybakina title clash in Toronto
-
British eccentrics push humble garden shed to new heights
-
Australia's Pallister shines, mixed relay record falls as Pan Pacs open
-
Zambia votes with president's economic record on the line
-
Hasan puts Bangladesh in charge as Australia struggle to 183-8
-
Germany's dry rivers spark battle on engineering vs restoration
-
Putin visits Kuril islands claimed by Japan
-
Senators demand inquiry into conditions aboard USS Abraham Lincoln
-
Swiatek downs Svitolina to reach first WTA final of 2026
-
All Blacks' Proctor out of South Africa series, Mo'unga called up
-
Jones says Japan 'watching videos of geese' for Australia clash
-
Bangladesh quick Hasan reduces Australia to 74-4 at lunch
-
Bloodied but unbowed, defending champ Shelton reaches Montreal final
-
Seoul tech leads Asian stock gains as traders cheer US inflation
-
Wallabies make eight changes for return Japan Test
-
Farage and Count Binface go head-to-head in snap UK poll
-
Messi returns after father's death but Miami knocked out of Leagues Cup
-
Afghan students divided over smartphone ban at universities
-
Outflanked by AI, stars fade for South Korea's blind fortune-tellers
-
Japan go back to school for second Australia Test
-
Venezuela govt, opposition wrap up round of post-Maduro talks
-
Matthew McConaughey on his sweet return to the big screen
-
Five things to know about Zambia as it goes to the polls
-
President's economic record on the line as Zambia votes
-
Nakashima holds off Jodar to book first ATP Masters final in Montreal
-
Battery X Metals Appoints Lithium-Ion Battery and Electric Vehicle Entrepreneur William Fan as President to Advance Development of Its Patent-Pending Lithium-Ion Battery Rebalancing Technology Platform and Corporate Growth Initiatives
-
Battery X Metals Maintains Y Lithium Project Claims in Good Standing and Evaluates Phase I Exploration Program
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - August 13
-
Battery X Metals Announces Closing of Second Tranche of Private Placement to Advance Corporate Growth Initiatives
-
3 Home Repairs You Can't Afford to Put Off
-
Grieving Messi available for Miami in Leagues Cup clash
-
Trump 'low-key' bets on economic pressure against Iran
-
Colombia enters 'final phase' of quake search as toll hits 265
-
Pitch invaders take selfies with Fernandes during Man Utd friendly
-
Father-figure Christie helps guide Kounta to European silver
-
No-stress Sabalenka won't fret over lackluster 2026 results
-
McIlroy returns to St. Jude to launch marathon PGA playoff push
-
Hometown hero Hudson-Smith basks in Euro glory
-
Guimaraes makes Arsenal debut in Como friendly
-
PSG down Aston Villa to retain UEFA Super Cup
-
Travis Kelce says wedding to Taylor Swift was 'best night of my life'
-
Trump's spokesperson Karoline Leavitt to step down
-
US stocks mostly up after data shows slightly lower inflation in July
-
'Imposing ignorance': US climate science under siege
-
Caracas protest denounces secrecy of Venezuela transition talks
-
As millions gazed in awe, a swathe of Spain plunged into darkness
-
Hudson-Smith regains Euro 400m title on home track
Activists on trial as France debates right to die
Twelve activists accused of helping people in France to illegally obtain a euthanasia drug went on trial in Paris on Monday, as the country debates a right-to-die bill.
The defendants, aged 74 to 89, are members of Ultime Liberte (Ultimate Freedom), an association that fights to legalise assisted dying in France.
They are accused of helping dozens of people purchase pentobarbital, a drug used for physician-assisted suicide in countries such as Belgium and Switzerland, between August 2018 and November 2020.
Many of them are retired teachers with no criminal record, now facing charges of trafficking illegal substances.
If convicted, they risk up to 10 years in prison, although any sentences are expected to be much more lenient, given mitigating factors including their age.
Bernard Senet, a doctor on trial, said he had helped people who were suffering to die in better conditions.
"I am at peace because I do not feel guilty," he said.
In France, pentobarbital is only authorised to euthanise animals, while in the United States, the drug is used to carry out executions.
Few countries regulate assisted dying, and in many it remains a crime to help someone end their life, even in cases of severe and incurable suffering.
In May, France's lower house of parliament approved a right-to-die bill on first reading, the initial step in a lengthy process that could grant patients medical assistance to end their lives in clearly defined circumstances.
- 'We are satisfied' -
Outside the Paris court, members of the association rallied in support of the defendants.
"We are satisfied that there is a trial so that we can bring (the issue) to public attention," Monique Denis, the wife of one of the defendants, told AFP.
"And perhaps public opinion will come out in favour of changing the law," the 69-year-old added.
Ultime Liberte's campaign goes beyond the demands of traditional pro-euthanasia associations, advocating the right to control the manner and timing of death, whether terminally ill or not.
"Suicide has been decriminalised since the Revolution but there are many laws that prevent the freedom to commit suicide, non-violent suicide," Claude Hury, head of Ultime Liberte, told AFP ahead of the trial.
"Our goal is not to kill people," Hury said, but to help people die with dignity.
"It is to help them continue to age while being very serene about the end, provided they have this magic pill at home so they can stop when they decide to, rather than waiting for the medical diktat."
The investigation began in 2019 following a US report on a network that shipped pentobarbital worldwide, disguised in bottles labelled "natural cosmetics".
France carried out searches across the country in 2019, finding buyers who were mostly elderly or seriously ill people, though some suicides appeared unrelated to age or illness.
The investigation found that some members of the association accompanied those wishing to die by giving them information on how to order the drug or even helping them obtain it.
By sharing the information only with those who requested it, the activists did not intend to "encourage or facilitate a decision to commit suicide" but rather to "accompany" that decision, said the investigating judge.
One member said he joined the association after a relative used the group to end their life.
"I am here to see if I can help in some way, so that when I'm 80 and ill, I won't have to do it behind closed doors," said the 61-year-old, releasing only his first name, Franck.
France's draft law would allow assisted dying only in an "advanced" stage of illness, which it defines as an irreversible and worsening health condition affecting someone's quality of life.
If approved, France would join a small group of European countries that give the right to aid in dying, including Austria, Germany, Spain and Switzerland.
The trial is set to conclude on October 9.
J.Gomez--AT